Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.500 | -0.310 | 0.1900 | ||||
REV | 15.410M | 16.373M | 963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
CTMX | CytomX Therapeutics | 7.78 | 0.18 | 2.37% | 504M |
You can purchase shares of CytomX Therapeutics (NASDAQ: CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: Gamida Cell (NASDAQ:GMDA), Jounce Therapeutics (NASDAQ:JNCE) and Inozyme Pharma (NASDAQ:INZY).
The latest price target for CytomX Therapeutics (NASDAQ: CTMX) was reported by Guggenheim on 2020-09-22. The analyst firm set a price target for 0.00 expecting CTMX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $7.78 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for CytomX Therapeutics.
There is no upcoming split for CytomX Therapeutics.